ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC trimmed its position in ARK Genomic Revolution ETF (BATS:ARKGFree Report) by 2.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,348 shares of the company’s stock after selling 466 shares during the period. Steward Partners Investment Advisory LLC’s holdings in ARK Genomic Revolution ETF were worth $504,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. BNP Paribas Financial Markets increased its position in shares of ARK Genomic Revolution ETF by 112.8% in the 4th quarter. BNP Paribas Financial Markets now owns 1,156,701 shares of the company’s stock valued at $37,951,000 after acquiring an additional 613,063 shares during the period. SG Americas Securities LLC grew its position in ARK Genomic Revolution ETF by 835.6% during the 4th quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock worth $6,990,000 after purchasing an additional 190,287 shares during the period. International Assets Investment Management LLC grew its position in ARK Genomic Revolution ETF by 120.1% during the 4th quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock worth $3,280,000 after purchasing an additional 58,715 shares during the period. Del Sette Capital Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth about $3,253,000. Finally, Longitude Cayman Ltd. grew its position in ARK Genomic Revolution ETF by 45.5% during the 4th quarter. Longitude Cayman Ltd. now owns 80,000 shares of the company’s stock worth $2,625,000 after purchasing an additional 25,000 shares during the period.

ARK Genomic Revolution ETF Stock Performance

Shares of ARKG opened at $26.45 on Friday. The stock’s fifty day moving average is $25.47 and its 200-day moving average is $28.48.

About ARK Genomic Revolution ETF

(Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

Featured Articles

Institutional Ownership by Quarter for ARK Genomic Revolution ETF (BATS:ARKG)

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.